Rabies immunoglobulin is mainly used for passive immunization of patients bitten and scratched by rabies or other animals carrying rabies virus. Market Analysis and Insights: Global Human Rabies Immune Globulin (HRIG) Market The global Human Rabies Immune Globulin (HRIG) market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Human Rabies Immune Globulin (HRIG) Scope and Market Size The global Human Rabies Immune Globulin (HRIG) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Rabies Immune Globulin (HRIG) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type 200IU 500IU Segment by Application Category II Exposure Category III Exposure The Human Rabies Immune Globulin (HRIG) market is analysed and market size information is provided by regions (countries). Segment by Application, the Human Rabies Immune Globulin (HRIG) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions. By Company CSL Behring Grifols Sanofi Sichuan Yuanda Shuyang CNBG Kamada CBPO Shuanglin Bio Weiguang Bio Shanghai RAAS Bharat Serum VINS
1 Human Rabies Immune Globulin (HRIG) Market Overview 1.1 Human Rabies Immune Globulin (HRIG) Product Scope 1.2 Human Rabies Immune Globulin (HRIG) Segment by Type 1.2.1 Global Human Rabies Immune Globulin (HRIG) Sales by Type (2016 & 2021 & 2027) 1.2.2 200IU 1.2.3 500IU 1.3 Human Rabies Immune Globulin (HRIG) Segment by Application 1.3.1 Global Human Ra
